SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-166810
Filing Date
2014-04-29
Accepted
2014-04-29 15:10:08
Documents
9
Period of Report
2014-06-13
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d715801ddef14a.htm DEF 14A 681952
2 GRAPHIC g715801g24q51.jpg GRAPHIC 1970
3 GRAPHIC g715801g27y79.jpg GRAPHIC 19340
4 GRAPHIC g715801g46c21.jpg GRAPHIC 7201
5 GRAPHIC g715801g49a08.jpg GRAPHIC 4723
6 GRAPHIC g715801g58k90.jpg GRAPHIC 51008
7 GRAPHIC g715801g68j17.jpg GRAPHIC 2045
8 GRAPHIC g715801pc1a.jpg GRAPHIC 3989
9 GRAPHIC g715801pc1b.jpg GRAPHIC 8254
  Complete submission text file 0001193125-14-166810.txt   819912
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-31161 | Film No.: 14793415
SIC: 2834 Pharmaceutical Preparations